Form 4: Director Bahija Jallal Acquires Elevance Health Stock

Director Bahija Jallal acquired 563 deferred stock units as part of the Elevance Health, Inc. Board of Directors Compensation Program.

Summary

• Director Bahija Jallal was granted 563 deferred stock units on May 13, 2026.
• The grant was issued under the Elevance Health, Inc. Board of Directors Compensation Program.
• Following this transaction, the director's total beneficial ownership of common stock is 5,351 shares.
• The units are payable in common stock upon the earlier of five years from the grant date or the director's departure from the board.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation with no material impact on company operations or financial outlook.

Positives

• The transaction reflects alignment between the director and shareholder interests through equity-based compensation.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

The deferred stock units are scheduled to be payable in common stock five years from the grant date or upon the director's cessation of board service.

Industry Context

StockSavvy.ai notes that equity-based compensation for board members is a standard corporate governance practice in the healthcare insurance sector to ensure long-term alignment with company performance.

Comparison to Industry Standards

• The use of deferred stock units for director compensation is consistent with standard practices among large-cap healthcare companies like UnitedHealth Group and Cigna.

Corporate Governance

Stakeholder Impact

• Minimal impact on shareholders as this is a standard compensation disclosure.

Next Steps

• The director will hold the units until the vesting conditions are met.

Key Dates

Keywords

Elevance Health, ELV, Form 4, Insider Transaction, Director Compensation, Deferred Stock Units